0001077183-19-000230.txt : 20191212
0001077183-19-000230.hdr.sgml : 20191212
20191212192827
ACCESSION NUMBER: 0001077183-19-000230
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191210
FILED AS OF DATE: 20191212
DATE AS OF CHANGE: 20191212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McKenzie Kathryn B
CENTRAL INDEX KEY: 0001720001
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35756
FILM NUMBER: 191283005
MAIL ADDRESS:
STREET 1: 12780 WESTLINKS DRIVE
CITY: FORT MYERS
STATE: FL
ZIP: 33913
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEOGENOMICS INC
CENTRAL INDEX KEY: 0001077183
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734]
IRS NUMBER: 742897368
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12701 COMMONWEALTH DRIVE
STREET 2: SUITE 9
CITY: FORT MYERS
STATE: FL
ZIP: 33913
BUSINESS PHONE: 9419231949
MAIL ADDRESS:
STREET 1: 12701 COMMONWEALTH DRIVE
STREET 2: SUITE 9
CITY: FORT MYERS
STATE: FL
ZIP: 33913
FORMER COMPANY:
FORMER CONFORMED NAME: AMERICAN COMMUNICATIONS ENTERPRISES INC
DATE OF NAME CHANGE: 19990120
4
1
wf-form4_157619689019440.xml
FORM 4
X0306
4
2019-12-10
0
0001077183
NEOGENOMICS INC
NEO
0001720001
McKenzie Kathryn B
12701 COMMONWEALTH DRIVE
SUITE 9
FORT MYERS
FL
33913
0
1
0
0
Chief Accounting Officer
Common Stock
2019-12-10
4
M
0
8000
8.03
A
10273
D
Common Stock
2019-12-10
4
S
0
8000
26.37
D
2273
D
Stock Option (Right to Buy)
8.03
2019-12-10
4
M
0
8000
0
D
2019-02-26
2023-02-26
Common Stock
8000.0
40000
D
Stock Option (Right to Buy)
9.07
2018-10-18
2022-10-18
Common Stock
25000.0
25000
D
Stock Option (Right to Buy)
19.6
2020-03-01
2024-03-01
Common Stock
13894.0
13894
D
On February 26, 2018, Ms. McKenzie was granted an option to purchase 48,000 shares of NeoGenomics, Inc. common stock. The options vest ratably over the first three anniversary dates of the grant date.
On October 18, 2017, Ms. McKenzie was granted an option to purchase 25,000 shares of NeoGenomics, Inc. common stock. The options vest ratably over the first three anniversary dates of the grant date.
On March 1, 2019, Ms. McKenzie was granted an option to purchase 13,894 shares of NeoGenomics, Inc. common stock. The options vest ratably over the first four anniversary dates of the grant date.
/s/ Kathryn McKenzie
2019-12-12